Main Menu
Main Menu
Stay updated with news and stories of strength and hope. Learn how biomarker testing is unlocking personalized treatment options and how clinical trials are offering new paths forward.
Q&A with a Pathologist (Part Two): Keith Ligon, MD, PhD The team at the National Brain Tumor Society interviewed Keith Ligon, MD, PhD, in part one of our series to help explain pathology and biomarker testing as part of NBTS’s MyTumorID campaign. NBTS launched the MyTumorID campaign this year to educate and empower patients and care partners to make informed decisions about biomarker testing and clinical […] October 7, 2024
Q&A with a Pathologist (Part One): Keith Ligon, MD, PhD The most recent WHO Classification of Tumours emphasizes the importance of biomarker testing in the diagnosis of brain tumors, yet nearly 70% of patients with brain tumors reported not understanding what biomarker testing is in a recent survey. National Brain Tumor Society launched the MyTumorID campaign this year to educate and empower patients and care […] August 27, 2024
Notes of Courage: Kai’s Childhood Cancer Story Eleven-year-old Kai C. sits down at his piano and masterfully plays his own composed song. The elementary student with an ear for music amazes his mother, Kari, as he improvises and creates pieces. With how effortlessly he moves over the keys, it might be hard to believe that Kai has experienced two recurrences, seven surgeries, […] August 26, 2024
Liz and Julio Piña Share Their Experience with Clinical Trials The National Comprehensive Cancer Network (NCCN) believes the best management of any patient with cancer is a clinical trial, but the idea of enrolling in a clinical trial may seem daunting. In this video, hear why Julio Piña, a patient with anaplastic ependymoma, and his wife Liz enrolled in a trial and what the process […] July 24, 2024
Demystifying Clinical Trials: A Mythbusting Guide for Patients with Brain Tumors and Care Partners In 1774, a British Royal Navy surgeon named James Lind began what is now referred to as the first randomized clinical trial when he divided 12 scurvy-stricken sailors into six groups and administered various treatments. Through meticulous observation and analysis, Lind discovered that the sailors who received citrus fruits experienced significant improvements in their symptoms, […] May 20, 2024
Have you undergone biomarker testing for your brain tumor or enrolled in a clinical trial? NBTS wants to hear from you!
This fall, join us for two free MyTumorID webinars designed to help patients and caregivers learn about biomarker testing (Sept. 26) and clinical trials (Oct. 24). Each session offers expert knowledge, firsthand insights, and resources to help you ask questions and make informed decisions about your treatment.
With MyTumorID, I decide.